#LiverResearch Archives

AASLD 2024: Dr. Mingqin Lu’s Team Presents Study on Biomimetic Exosomes Loaded with Iridium Nanozyme for Acute Liver Failure Treatment

By Mourabit Halima 2024.12.17

At the 2024 American Association for the Study of Liver Diseases (AASLD) Annual Meeting, Professor Mingqin Lu’s team from The First Affiliated Hospital of Wenzhou Medical University unveiled their latest…

AASLD 2024丨Dr. Xiaohong Gao: Initiating TDF at Different Gestational Weeks Safely Prevents HBV Mother-to-Child Transmission

By Lisa Cui 2024.12.06

Despite extensive research, there remains no universal consensus on the optimal timing for initiating antiviral therapy during pregnancy to prevent hepatitis B virus (HBV) mother-to-child transmission (MTCT). Divergent recommendations have…

AASLD’s Chinese Impact: Dr. Liang Peng’s Team Achieves Multiple Research Milestones in Chronic Hepatitis B and Related Liver Failure

By El Bachir MOURABIT 2024.12.03

From November 15-19, 2024, the 75th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) was held in San Diego, USA. At this prestigious event, Dr.…

Dr. Wai-Kay Seto’s team: Multiple Studies on Hepatic Diseases Management with New Hepatitis B Drugs, Fatty Liver Monitoring, and Liver Cancer Risk Factors

By Lisa Cui 2024.01.14

The 58th Annual Meeting of the European Association for the Study of the Liver (EASL2023) and the EASL Congress 2023 have come to a close. During this conference, Dr. Wai-Kay…

Seven Achievements from Peking University Hepatology Institute Shine at EASL 2023

By Mourabit Halima 2023.12.25

From June 21st to 24th, the annual international liver disease conference, the 58th Annual Meeting of the European Association for the Study of the Liver (EASL 2023) and EASL Congress…

Dr. Youwen Tan: Baseline Hepatocyte Ballooning is a Risk Factor for the Evolution of Non-Alcoholic Fatty Liver Disease in Chronic Hepatitis B

By Peter W. PENG 2023.12.21

Chronic hepatitis B (CHB) and non-alcoholic fatty liver disease (NAFLD) are both significant contributors to liver-related complications and mortality. Dr. Youwen Tan's team at the Third People's Hospital of Jiangsu…